Dr Regueiro, professor and chair of the Department of Gastroenterology, Hepatology, and Nutrition at the Cleveland Clinic, spoke to the Advances in Inflammatory Disease regional meeting on April 16 about the potential and promise of a new therapeutic agent, S1P modulators.